• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮、甲氧氯普胺和甲硝唑相互作用导致尖端扭转型室性心动过速

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes.

作者信息

Gnanapandithan Karthik, Karthik Nishrutha, Gerber Jaime

机构信息

Department of Internal Medicine, Mayo Clinic, 3500 San Pablo Road S, Jacksonville, FL 32224, USA.

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.

出版信息

Clin Pract. 2021 Feb 7;11(1):101-105. doi: 10.3390/clinpract11010015.

DOI:10.3390/clinpract11010015
PMID:33562182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7931031/
Abstract

There are several classes of medications that can cause prolongation of the corrected QT (QTc) interval and potentially Torsades de Pointes (TdP). Most of these medications are commonly used in the emergency department, and interaction between these medications increases the risk of this iatrogenic complication. We describe a patient on methadone therapy who developed TdP after she received metoclopramide and metronidazole. Interaction between different classes of medications can increase the risk of QTc prolongation and TdP. Awareness of this condition and its risk factors need continuous reinforcement among all hospital personnel to reduce the risk of this life-threatening complication.

摘要

有几类药物可导致校正QT(QTc)间期延长,并可能引发尖端扭转型室速(TdP)。这些药物大多常用于急诊科,而这些药物之间的相互作用会增加这种医源性并发症的风险。我们描述了一名接受美沙酮治疗的患者,她在接受甲氧氯普胺和甲硝唑后发生了TdP。不同类药物之间的相互作用会增加QTc延长和TdP的风险。所有医院工作人员都需要持续强化对这种情况及其危险因素的认识,以降低这种危及生命并发症的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5430/7931031/40e9050f172a/clinpract-11-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5430/7931031/40e9050f172a/clinpract-11-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5430/7931031/40e9050f172a/clinpract-11-00015-g001.jpg

相似文献

1
Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes.美沙酮、甲氧氯普胺和甲硝唑相互作用导致尖端扭转型室性心动过速
Clin Pract. 2021 Feb 7;11(1):101-105. doi: 10.3390/clinpract11010015.
2
Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?城市贫困人群中的药物性尖端扭转型室性心动过速。美沙酮:是否存在治疗权衡?
J Interv Card Electrophysiol. 2016 Jan;45(1):37-45. doi: 10.1007/s10840-015-0077-2. Epub 2015 Nov 20.
3
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.QT 间期延长与尖端扭转型室性心动过速风险:临床医生必备知识。
Curr Med Res Opin. 2013 Dec;29(12):1719-26. doi: 10.1185/03007995.2013.840568. Epub 2013 Sep 23.
4
Methadone induced torsades de pointes and ventricular fibrillation: A case review.美沙酮诱发尖端扭转型室速和心室颤动:病例回顾
ARYA Atheroscler. 2014 Nov;10(6):339-42.
5
Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?美沙酮、QTc间期延长与尖端扭转型室性心动过速:当前概念、管理及故事中的一个隐藏转折?
J Cardiovasc Dis Res. 2013 Dec;4(4):229-35. doi: 10.1016/j.jcdr.2013.10.001. Epub 2013 Nov 16.
6
The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.静脉注射氟哌啶醇对重症患者QT间期离散度的影响:与QT间期延长比较以评估尖端扭转型室速风险
J Clin Pharmacol. 2001 Dec;41(12):1310-8. doi: 10.1177/00912700122012896.
7
QTc prolongation, torsades de pointes, and psychotropic medications.QTc 延长、尖端扭转型室性心动过速和精神类药物。
Psychosomatics. 2013 Jan-Feb;54(1):1-13. doi: 10.1016/j.psym.2012.11.001.
8
New Generation Antipsychotic Drugs and QTc Interval Prolongation.新一代抗精神病药物与QTc间期延长
Prim Care Companion J Clin Psychiatry. 2003 Oct;5(5):205-215. doi: 10.4088/pcc.v05n0504.
9
Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.医学毒理学家对过量用药患者药物诱导的QT间期延长的实践模式:一项在美国、欧洲和亚太地区开展的调查。
Clin Toxicol (Phila). 2015 May;53(4):204-9. doi: 10.3109/15563650.2015.1013547. Epub 2015 Feb 23.
10
Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting.在急诊科环境中,女性低钾血症和美沙酮治疗是与QT间期延长相关的最强非心脏因素。
J Electrocardiol. 2017 Jul-Aug;50(4):416-423. doi: 10.1016/j.jelectrocard.2017.02.001. Epub 2017 Feb 10.

引用本文的文献

1
A fatal case of repeated ventricular fibrillation due to torsade de pointes following repeated administration of metoclopramide.一例因反复使用甲氧氯普胺后发生尖端扭转型室速导致反复心室颤动的致死病例。
Clin Case Rep. 2022 Aug 9;10(8):e6213. doi: 10.1002/ccr3.6213. eCollection 2022 Aug.

本文引用的文献

1
Opioids and Cardiac Arrhythmia: A Literature Review.阿片类药物与心律失常:文献综述。
Med Princ Pract. 2018;27(5):401-414. doi: 10.1159/000492616. Epub 2018 Aug 2.
2
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054. Epub 2018 Aug 16.
3
Emergency department approach to QTc prolongation.
急诊科处理QTc间期延长的方法。
Am J Emerg Med. 2017 Dec;35(12):1928-1933. doi: 10.1016/j.ajem.2017.08.044. Epub 2017 Aug 24.
4
CredibleMeds.org: What does it offer?可信药物网:它提供了什么?
Trends Cardiovasc Med. 2018 Feb;28(2):94-99. doi: 10.1016/j.tcm.2017.07.010. Epub 2017 Aug 1.
5
A systematic review of the cardiotoxicity of methadone.美沙酮心脏毒性的系统评价。
EXCLI J. 2015 May 5;14:577-600. doi: 10.17179/excli2015-553. eCollection 2015.
6
QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.体表心电图QT间期变异性:测量、生理基础及临床价值:欧洲心律协会联合欧洲心脏病学会心脏细胞电生理工作组认可的立场声明及共识指南
Europace. 2016 Jun;18(6):925-44. doi: 10.1093/europace/euv405. Epub 2016 Jan 27.
7
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People.住院老年人中与使用延长QT间期药物相关的患病率及危险因素
Drugs Aging. 2016 Jan;33(1):53-61. doi: 10.1007/s40266-015-0337-y.
8
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.医院环境中尖端扭转型室速的预防:美国心脏协会和美国心脏病学基金会的科学声明
Circulation. 2010 Mar 2;121(8):1047-60. doi: 10.1161/CIRCULATIONAHA.109.192704. Epub 2010 Feb 8.
9
Metoclopramide as a possible cause of prolonged QT syndrome and torsade de pointes in a patient with heart failure and renal insufficiency.
Ann Intern Med. 2009 Apr 7;150(7):502-4. doi: 10.7326/0003-4819-150-7-200904070-00016.
10
QTc interval screening in methadone treatment.美沙酮治疗中的QTc间期筛查
Ann Intern Med. 2009 Mar 17;150(6):387-95. doi: 10.7326/0003-4819-150-6-200903170-00103. Epub 2009 Jan 19.